retatrutide joint pain delivers on improving knee with unsurpassed weight loss GLP1s & joint pain and

This finding shaped the expected commercial dosing strategy: start low, go slow

A wave of VC-backed startups and PE-backed companies are rebranding compounding as a tech-enabled, consumer-first digital health service

Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes

At maximum doses, retatrutide has higher rates of nausea (43% vs 31%), vomiting (21% vs 12%), diarrhea (33% vs 23%), and constipation (25% vs 11%) compared to tirzepatide

Beyond their metabolic effects, GLP-1s possess robust anti-inflammatory properties

Sensing of these various things then leads to varying downstream reactions as shown in this For our purposes we want to focus on the anti-inflammatory aspect